Humana’s CenterWell JV Rewrites the Control Package
Humana’s CenterWell deal shows the new JV playbook: separate the economics, control, and exit rights before the deal is even signed.
What is this trend?
Humana’s CenterWell restructuring shows healthcare JVs are now being split into separate deals for ownership, control, operating rights, and future buyback options.
- BlackRock’s HPS is buying WCAS’s stake, making the JV majority-owned by BlackRock.
- Humana keeps a minority stake but continues to run the clinics.
- A 2028 option lets Humana repurchase JV-owned sites, separating exit rights from equity.
- Control and governance are being priced apart from pure ownership economics.
- Corp dev teams must lock board, operating, and repurchase terms earlier in the process.
What’s the latest?
Humana’s October 13 CenterWell restructuring pushes the story one step further: BlackRock’s HPS Investment Partners will buy WCAS’s roughly $2.8 billion stake, the new JV will be majority-owned by Bla
How it developed
Go deeper
Curated long-form picks on this trend — podcasts, videos, and analysis, by seniority.
If you lead the organization
Beyond IT Governance: Why Clinical Technology Requires Its Own Operating Model | Healthcare IT Today
Analysis by Tanya M. Martin on a clinical tech operating model, tying governance to patient-care outcomes.
Healthcare IT Today · News
Read →How health systems can build a scalable model for advanced practice providers
How-to news explainer on building scalable APP operating models—governance, roles, metrics, economics—for enterprise value.
Becker's Hospital Review · News
Read →